GFAP and Dravet syndrome: In this study, we show, for the first time to our knowledge, that in participants with DS, p-tau217 and GFAP but not other plasma AD biomarkers (ie, Aβ42/Aβ40, t-tau, and NfL) were associated with tau-PET status when accounting for age.